In Re Cree, Inc. Securities Litigation

333 F. Supp. 2d 461, 2004 U.S. Dist. LEXIS 17752, 2004 WL 1950308
District Court, M.D. North Carolina·Decided August 27, 2004·No. 1:03 CV 00549·Published·Cited by 15 cases

Opinion

" MEMORANDUM OPINION

BULLOCK, District Judge.

Plaintiffs bring this. consolidated class action lawsuit against Defendant corporation Cree, Inc. (“Cree”) and various Cree officers and directors, including F. Neal Hunter, Cynthia B. Merrell, John W. Palmour, Charles Swoboda, Calvin H. Carter, James E. Dykes, Dolph W. Von Arx, and Walter L. Robb (collectively “Defendants”). Plaintiffs allege that Defendants engaged in fraudulent business practices designed to artificially inflate Cree’s stock price. Plaintiffs bring claims for securities fraud pursuant to Sections 10(b), 18, 20(a), and 20(A) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b), 78r, 78t(a), and 78t-1(a), Rule 10b-5 promulgated under Section 10 of the Exchange Act, 17 C.F.R. § 240.10b-5, and Section 304 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. § 7243. Before the court is Defendants’ motion to dismiss the complaint as untimely and deficient under the heightened pleading requirements of the Private Securities Litigation Reform Act of 1995, 15 U.S.C. § 78u-4 et seq. (“PSLRA”). Also before the' court is Plaintiffs’ motion to strike certain of Defendants’ exhibits submitted in support of their motion to dismiss. For the following reasons, the court will grant Defendants’ motion to dismiss without prejudice. The court also will grant Plaintiffs’ motion to strike Defendants’ Exhibits 8, 21-25, 30, and 47 attached to the Declaration of Nicholas I. Porritt in Support of Defendants’ Motion to Dismiss. Plaintiffs’ motion to strike Defendants’ Exhibit 18 will be denied.

*466 FACTS

Cree, a North Carolina company headquartered in Durham, North Carolina, develops and markets products made from silicon carbide. The company is a leading manufacturer of semiconductors, transistors, and light-emitting diodes (“LEDs”). On June 12, 2003, Eric Hunter, a former Chief Executive Officer (“CEO”) and co-founder of Cree, filed suit against Cree and various- Cree executives, including his brother and co-founder, F. Neal Hunter (“Neal Hunter”). 1 In his brief initial complaint, Eric Hunter sued Cree for securities fraud, violations of the whistle-blower provisions of Section 806 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A, and defamation. Cree’s stock price fell 18.5% upon announcement of the suit. 2

Four days after Eric Hunter filed his complaint, the first of nineteen securities fraud class action suits were filed against Cree. On November 25, 2003, the court held a hearing to consolidate the cases and name a lead plaintiff for the putative class. Louisiana Teachers’ Retirement System was selected as lead plaintiff. The class has not been certified.

On January 16, 2004, Plaintiffs filed a Consolidated Class Action Complaint (“the complaint”). Plaintiffs seek to represent purchasers of Cree stock during an approximately four-year period from August 12, 1999 to June 13, 2003 (the proposed “class period”). The complaint alleges that throughout this period Defendants made numerous omissions and misleading statements in Cree’s press releases and public filings. These allegations center on Cree’s business relationships with six companies, some of which were owned or operated by other members of the Hunter family.

Round-Trip Transactions

Plaintiffs’ round-trip allegations concern Cree’s business dealings with Microvision, Inc. (“Microvision”), Spectrian Corporation (“Spectrian”), World Theatre, Inc. (“WTI”), Xemod, Inc. (“Xemod”), and Lighthouse Tephnologies Ltd. (“Lighthouse”). According to Cree’s disclosures, Cree invested in these companies and entered into agreements to receive research and development (“R & D”) funding from them. Plaintiffs contend that these agreements were in fact a method by which Cree “round-tripped” its own funds, improperly improving its financial performance by purchasing its own revenue and earnings.

For example, during the class period, Cree invested $12.5 million in Microvision, and Microvision agreed to fund $10 million worth of Cree R & D. Plaintiffs allege that Cree overpaid for its investment in Micro-vision pursuant to a secret agreement requiring Microvision to return the funds to Cree for R & D that Cree never performed. Plaintiffs support this claim with statements by an unnamed Microvision vice president primarily responsible for Microvision’s R & D and a former Microvision project manager.

In addition to alleging round-trip transactions involving Microvision, Plaintiffs claim that Cree used its relationship with Spectrian to inflate its stock price and *467 financial- outlook. In December 2000, Cree acquired UltraRF, a subsidiary of Spectri-an, for $100 million. Cree allocated $81.6 million of the purchase price to goodwill and the remainder to UltraRF’s tangible and specific intangible assets. At the time of purchase, Cree and Spectrian also entered into a development agreement for $2.4 million in R & D funding and a Purchase and Supply Agreement under which Spectrian would buy $58 million worth of Cree products over two years. In October 2001 and again in March 2002, the parties modified the Purchase and Supply Agreement to reduce Spectrian’s obligations. Subsequently, Cree wrote down $76.5 million of UltraRF’s assets and goodwill as impaired. The Purchase and Supply Agreement ultimately terminated in November 2002 upon a $5 million payment from Spectrian.

According to Plaintiffs, Cree’s deal with Spectrian was secretly designed as another way to round-trip Cree’s funds. The complaint alleges that Cree overpaid to acquire UltraRF and that the development and supply agreements were phony because “Cree had no experience manufacturing” products for Spectrian, “knew it did not have the ability to perform the R & D contemplated in Cree’s agreements with Spectrian,” and never actually conducted R & D for Spectrian. (ComplJ 168.) To. support these assertions, Plaintiffs reference several sources, including two employees and Eric Hunter.

Plaintiffs allege that Cree continued to manipulate its financials by engaging in comparable round-trip schemes with WTI, Xemod, and Lighthouse. In its public filings, Cree disclosed its investments in these companies and identified them as sources of R & D funding. Cree also subsequently disclosed substantial write-downs of each of these investments.

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Cree, Inc. Securities Litigation, 333 F. Supp. 2d 461, 2004 U.S. Dist. LEXIS 17752, 2004 WL 1950308 (M.D.N.C. 2004).

333 F. Supp. 2d 461 (In Re Cree, Inc. Securities Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Barnett v. United States
D. South Carolina, 2023
Bradacs v. Haley
58 F. Supp. 3d 499 (D. South Carolina, 2014)
Cohen v. Stevanovich
722 F. Supp. 2d 416 (S.D. New York, 2010)
Lane v. Page
649 F. Supp. 2d 1256 (D. New Mexico, 2009)
Teachers' Retirement System v. Cree Inc.
477 F.3d 162 (Fourth Circuit, 2007)
Teachers' Retirement System Of Louisiana v. Hunter
477 F.3d 162 (Fourth Circuit, 2007)
In Re Mutual Funds Investment Litigation
478 F. Supp. 2d 833 (D. Maryland, 2007)
In Re Trex Co., Inc. Securities Litigation
454 F. Supp. 2d 560 (W.D. Virginia, 2006)
Payne v. DeLuca
433 F. Supp. 2d 547 (W.D. Pennsylvania, 2006)
Iron Workers Local 16 Pension Fund v. Hilb Rogal & Hobbs Co.
432 F. Supp. 2d 571 (E.D. Virginia, 2006)
Neer v. Pelino
389 F. Supp. 2d 648 (E.D. Pennsylvania, 2005)
In Re Acterna Corp. Securities Litigation
378 F. Supp. 2d 561 (D. Maryland, 2005)